generic drug; prescription drug; act; coronavirus disease 2019; drug approval; drug cost; drug industry; drug manufacture; drug shortage; emergency use authorization; Food and Drug Administration; human; implementation science; leadership; medicaid; medicare; national health organization; note; pandemic; pharmacy benefit manager; politics; prescription